Nanoassemblies

纳米组装体
  • 文章类型: Journal Article
    负载在巨噬细胞(MAs)中的纳米药物可以主动靶向肿瘤,而不会主要依赖于增强的通透性和保留(EPR)效应,使它们有效治疗缺乏EPR的恶性肿瘤。在这里,合成具有光动力和化学动力功能的铜交联碳点簇(CDCs)来操纵MA,旨在指导MA介导的肿瘤靶向。首先,通过一步水热法制备绿色荧光CD(g-CD)。随后,g-CDs与二价铜离子络合形成铜交联的CDCs(g-CDCs/Cu),它们与MA一起孵化用于操纵。实验结果表明,制备的g-CDCs/Cu具有良好的水分散性和荧光发射性能。可以通过组合的Cu介导的化学动力学疗法和CD介导的光动力学疗法在激光照射的存在下激活纳米组装体以耗尽过表达的谷胱甘肽(GSH)并产生活性氧(ROS)。此外,MA中产生的ROS使MA极化为抗肿瘤M1表型,提示未来潜在的逆转免疫抑制肿瘤微环境的用途。从当前研究中获得的这些结果表明,开发g-CDCs/Cu用于GSH消耗的巨大潜力,ROS生成,和MAM1极化作为一种治疗癌症的药物。
    Nanomedicines loaded in macrophages (MAs) can actively target tumors without dominantly relying on the enhanced permeability and retention (EPR) effect, making them effective for treating EPR-deficient malignancies. Herein, copper-crosslinked carbon dot clusters (CDCs) are synthesized with both photodynamic and chemodynamic functions to manipulate MAs, aiming to direct the MA-mediated tumor targeting. First, green fluorescent CDs (g-CDs) are prepared by a one-step hydrothermal method. Subsequently, the g-CDs are complexed with divalent copper ions to form copper-crosslinked CDCs (g-CDCs/Cu), which are incubated with MAs for their manipulation. Experimental results revealed that the prepared g-CDCs/Cu displayed good aqueous dispersibility and fluorescent emission properties. The nanoassemblies can be activated to deplete the overexpressed glutathione (GSH) and generate reactive oxygen species (ROS) in the presence of laser irradiation through the combined Cu-mediated chemodynamic therapy and CD-mediated photodynamic therapy. Furthermore, the ROS produced in MAs enabled polarization of MAs to antitumor M1 phenotype, suggesting the future potential use to reverse the immunosuppressive tumor microenvironment. These results obtained from the current study suggest a significant potential to develop g-CDCs/Cu for GSH depletion, ROS generation, and MA M1 polarization as a theransotic agent to tackle cancer.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    具有光响应性的纳米材料由于其荧光成像而引起了人们的关注,光动力,和光热治疗特性。在这项研究中,通过使用光敏剂和碳点(CD)开发了光响应性纳米组装体。由于它们的多个激发峰和多色荧光发射,特别是它们的膜渗透特性,这些纳米组件可以用多种颜色标记细胞,并实时跟踪细胞成像。此外,光敏剂和CD的掺入为纳米组装体提供了用于光动力疗法(PDT)和光热疗法(PTT)的潜力。纳米组装体通过PDT和PTT有效抑制大肠杆菌和金黄色葡萄球菌的活性。此外,纳米组装体对大肠杆菌和金黄色葡萄球菌表现出高亲和力。这些不同的特征赋予纳米组装体广谱抗菌性质。作为光响应性纳米平台,这些纳米组装体在生物成像和抗菌领域具有潜在的应用前景。
    Nanomaterials with photoresponsivity have garnered attention due to their fluorescence imaging, photodynamic, and photothermal therapeutic properties. In this study, a photoresponsivity nanoassembly was developed by using photosensitizers and carbon dots (CDs). Due to their multiple excitation peaks and multicolor fluorescence emission, especially their membrane-permeating properties, these nanoassemblies can label cells with multiple colors and track cell imaging in real time. Additionally, the incorporation of photosensitizers and CDs provides the nanoassemblies with the potential for photodynamic therapy (PDT) and photothermal therapy (PTT). The nanoassemblies effectively suppressed the activity of Escherichia coli and Staphylococcus aureus through PDT and PTT. Moreover, the nanoassemblies exhibited a high affinity for E. coli and S. aureus. These distinct features confer broad-spectrum antibacterial properties to the nanoassemblies. As a photoresponsivity nanoplatform, these nanoassemblies have demonstrated potential applications in the fields of bioimaging and antimicrobial.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    动脉粥样硬化,一种慢性和进行性疾病,其特征是炎症细胞和脂质在动脉壁内积聚,仍然是全球心血管疾病的主要原因。尽管在治疗动脉粥样硬化的药物治疗策略方面取得了相当大的进步,对于动脉粥样硬化,仍需要更有效的治疗方案.在这种追求中,β-环糊精(β-CD)作为一种有前途的治疗剂的出现为靶向动脉粥样硬化的药物递送提供了一种新的治疗方法。β-CD的疏水腔有利于其作为载体的作用,能够将各种治疗化合物封装和递送到脉管系统内受影响的部位。值得注意的是,基于β-CD的纳米组装体具有降低胆固醇水平的能力,减轻炎症,溶解疏水性药物并将药物输送到受影响的组织,使这些纳米组件有希望的候选动脉粥样硬化的管理。这篇综述集中在三大类基于β-CD的纳米组装体,包括基于β-CD的衍生物,基于β-CD/聚合物共轭物和基于聚合物β-CD的纳米组装体,强调各种配方和组装方法,以改善药物输送和治疗效果。这些基于β-CD的纳米组装体表现出多种治疗动脉粥样硬化的机制,并提供了克服药物递送障碍的系统策略。最后,我们讨论了基于β-CD的纳米组装体作为管理动脉粥样硬化和解决心血管疾病的新疗法的开发和应用中的当前障碍和潜在机会。
    Atherosclerosis, a chronic and progressive condition characterized by the accumulation of inflammatory cells and lipids within artery walls, remains a leading cause of cardiovascular diseases globally. Despite considerable advancements in drug therapeutic strategies aimed at managing atherosclerosis, more effective treatment options for atherosclerosis are still warranted. In this pursuit, the emergence of β-cyclodextrin (β-CD) as a promising therapeutic agent offers a novel therapeutic approach to drug delivery targeting atherosclerosis. The hydrophobic cavity of β-CD facilitates its role as a carrier, enabling the encapsulation and delivery of various therapeutic compounds to affected sites within the vasculature. Notably, β-CD-based nanoassemblies possess the ability to reduce cholesterol levels, mitigate inflammation, solubilize hydrophobic drugs and deliver drugs to affected tissues, making these nanocomponents promising candidates for atherosclerosis management. This review focuses on three major classes of β-CD-based nanoassemblies, including β-CD derivatives-based, β-CD/polymer conjugates-based and polymer β-CD-based nanoassemblies, highlighting a variety of formulations and assembly methods to improve drug delivery and therapeutic efficacy. These β-CD-based nanoassemblies exhibit a variety of therapeutic mechanisms for atherosclerosis and offer systematic strategies for overcoming barriers to drug delivery. Finally, we discuss the present obstacles and potential opportunities in the development and application of β-CD-based nanoassemblies as novel therapeutics for managing atherosclerosis and addressing cardiovascular diseases.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    有效应对复杂病理状况的关键方面之一是在空间和时间上精确地递送所需的治疗化合物。因此,对核靶向运载系统的关注已经成为一项潜力巨大的有希望的战略,特别是在基因治疗和癌症治疗中。这里,我们探索了超分子纳米组装体作为载体的设计,以将特定化合物传递到细胞核,特别关注暴露核定位信号的聚合物和基于肽的载体。这样的纳米组装体旨在最大化细胞核内遗传和治疗剂的浓度,从而优化治疗结果,同时最小化脱靶效应。复杂的情况,包括细胞摄取,内体逃逸,和核易位,需要微调纳米载体的属性。首先,我们介绍了核导入的原理和核孔复合物的作用,揭示了纳米系统靶向核的策略。然后,我们概述了依赖于核定位以实现最佳活性的货物,因为它们的完整性和积累是设计合适的输送系统时需要考虑的关键参数。考虑到他们正处于研究的早期阶段,我们提出了各种货物负载的肽和聚合物纳米组装,促进核靶向,强调它们增强治疗反应的潜力。最后,我们简要讨论了更精确和有效的核输送的进一步进展。
    One of the key aspects of coping efficiently with complex pathological conditions is delivering the desired therapeutic compounds with precision in both space and time. Therefore, the focus on nuclear-targeted delivery systems has emerged as a promising strategy with high potential, particularly in gene therapy and cancer treatment. Here, we explore the design of supramolecular nanoassemblies as vehicles to deliver specific compounds to the nucleus, with the special focus on polymer and peptide-based carriers that expose nuclear localization signals. Such nanoassemblies aim at maximizing the concentration of genetic and therapeutic agents within the nucleus, thereby optimizing treatment outcomes while minimizing off-target effects. A complex scenario of conditions, including cellular uptake, endosomal escape, and nuclear translocation, requires fine tuning of the nanocarriers\' properties. First, we introduce the principles of nuclear import and the role of nuclear pore complexes that reveal strategies for targeting nanosystems to the nucleus. Then, we provide an overview of cargoes that rely on nuclear localization for optimal activity as their integrity and accumulation are crucial parameters to consider when designing a suitable delivery system. Considering that they are in their early stages of research, we present various cargo-loaded peptide- and polymer nanoassemblies that promote nuclear targeting, emphasizing their potential to enhance therapeutic response. Finally, we briefly discuss further advancements for more precise and effective nuclear delivery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    表面合成是一种强大的方法,最近出现了在基于聚合的表面上制造各种原子级精确的纳米材料。在多相催化的框架内热活化反应非常成功。因此,它往往缺乏选择性。我们建议使用特定键的选择性活化作为关键成分来合成具有高选择性的所需分子。在这种方法中,预计在光解活化的表面反应中以高选择性产生热不可接近的产物。我们证明了在Cu(111)上组装的2,2'-二溴联苯簇,热和光解活化产生明显不同的产物,通过扫描隧道显微镜将真实空间成像中单个产物分子的亚分子分辨率与X射线光电子能谱中的化学鉴定相结合,并得到从头计算的支持。2,2'-二溴联苯的光活化Ullmann偶联具有高度选择性,只有一个确定的产品。它与热反应形成鲜明对比,产生各种产物,因为替代途径在反应温度下被激活。我们的研究将表面合成扩展到通过直接键活化直接形成热不可接近的产物。它承诺在基于特定键的光解活化的表面合成框架内定制纳米材料的反应。
    On-surface synthesis is a powerful method that has emerged recently to fabricate a large variety of atomically precise nanomaterials on surfaces based on polymerization. It is very successful for thermally activated reactions within the framework of heterogeneous catalysis. As a result, it often lacks selectivity. We propose to use selective activation of specific bonds as a crucial ingredient to synthesize desired molecules with high selectivity. In this approach, thermally nonaccessible products are expected to arise in photolytically activated on-surface reactions with high selectivity. We demonstrate for assembled 2,2\'-dibromo biphenyl clusters on Cu(111) that the thermal and photolytic activations yield distinctly different products, combining submolecular resolution of individual product molecules in real-space imaging by scanning tunneling microscopy with chemical identification in X-ray photoelectron spectroscopy and supported by ab initio calculations. The photolytically activated Ullmann coupling of 2,2\'-dibromo biphenyl is highly selective, with only one identified product. It starkly contrasts the thermal reaction, which yields various products because alternate pathways are activated at the reaction temperature. Our study extends on-surface synthesis to a directed formation of thermally inaccessible products by direct bond activation. It promises tailored reactions of nanomaterials within the framework of on-surface synthesis based on the photolytic activation of specific bonds.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    由于其在肿瘤组织和癌细胞中发现的生物学相关性,通过酸不稳定键的裂解而可降解的智能纳米组装体吸引了大量关注。尽管它们具有肿瘤靶向药物递送的高潜力,表现出受控/增强的药物释放,对影响这些功能的pH敏感性的结构因素的系统理解仍然具有挑战性,特别是适合于开发有效的酸可降解壳可脱落纳米组件的连接酸不稳定键的设计。在这里,我们报告了通过酸催化水解三种缩醛和缩酮二醇的合成和酸响应降解,并确定了苯甲醛缩醛(BzAA)在目标pH范围内表现出最佳水解曲线(例如,pH=5.0-6.5)是连接酸不稳定键的合适候选者。我们探索了定义明确的基于聚(乙二醇)的嵌段共聚物的合成和水性胶束化,该共聚物具有共价连接到聚甲基丙烯酸酯嵌段的BzAA键,用于在核/电晕界面形成具有BzAA基团的胶体稳定的纳米组装体。有希望的,我们对酸催化水解和酸响应性拆解的研究表明,形成的纳米组装体符合可酸降解壳脱落的纳米组装体的标准:在肿瘤pH=6.5时缓慢降解,在内/溶酶体pH=5.0时快速拆解,而在生理pH=7.4时胶体稳定性。这项工作指导了在界面处承载BzAA的酸可降解壳可脱落纳米组件的设计原理,从而为解决肿瘤靶向药物递送中的PEG困境和改善内吞提供了希望。本文受版权保护。保留所有权利。
    Smart nanoassemblies degradable through the cleavage of acid-labile linkages have attracted significant attention because of their biological relevance found in tumor tissues. Despite their high potential to achieve controlled/enhanced drug release, a systematic understanding of structural factors that affect their pH sensitivity remains challenging, particulary in the consruction of effective acid-degradable shell-sheddable nanoassemblies. Herein, the authors report the synthesis and acid-responsive degradation through acid-catalyzed hydrolysis of three acetal and ketal diols and identify benzaldehyde acetal (BzAA) exhibiting optimal hydrolysis profiles in targeted pH ranges to be a suitable candidate for junction acid-labile linkage. The authors explore the synthesis and aqueous micellization of well-defined poly(ethylene glycol)-based block copolymer bearing BzAA linkage covalently attached to a polymethacrylate block for the formation of colloidally-stable nanoassemblies with BzAA groups at core/corona interfaces. Promisingly, the investigation on acid-catalyzed hydrolysis and disassembly shows that the formed nanoassemblies meet the criteria for acid-degradable shell-sheddable nanoassemblies: slow degradation at tumoral pH = 6.5 and rapid disassembly at endo/lysosomal pH = 5.0, while colloidal stability at physiological pH = 7.4. This work guides the design principle of acid-degradable shell-sheddable nanoassemblies bearing BzAA at interfaces, thus offering the promise to address the PEG dilemma and improve endocytosis in tumor-targeting drug delivery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    自组装前药通常由药物模块组成,激活模块,和组装模块。通过选择合适的模块来保持功效和安全性之间的平衡仍然是开发前药纳米组装体的挑战。本研究设计了四种多西他赛(DTX)前药,使用二硫键作为活化模块,使用不同长度的支链脂肪醇作为组装模块(C16,C18,C20和C24)。组装模块的长度决定了前药的自组装能力,并影响了激活模块的敏感性。碳链的延伸改善了前药的自组装能力和药代动力学行为,同时降低了细胞毒性并增加了累积毒性。C20的使用可以平衡疗效和安全性。这些结果为前药纳米组装体的合理设计提供了参考。
    The self-assembly prodrugs are usually consisted of drug modules, activation modules, and assembly modules. Keeping the balance between efficacy and safety by selecting suitable modules remains a challenge for developing prodrug nanoassemblies. This study designed four docetaxel (DTX) prodrugs using disulfide bonds as activation modules and different lengths of branched-chain fatty alcohols as assembly modules (C16, C18, C20, and C24). The lengths of the assembly modules determined the self-assembly ability of prodrugs and affected the activation modules\' sensitivity. The extension of the carbon chains improved the prodrugs\' self-assembly ability and pharmacokinetic behavior while reducing the cytotoxicity and increased cumulative toxicity. The use of C20 can balance efficacy and safety. These results provide a great reference for the rational design of prodrug nanoassemblies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    来自两亲性大分子的刺激响应性纳米组装体可以经历受控的结构转变,并在刺激下产生不同的宏观现象。由于可控的响应,它们已被应用于广泛的材料和生物医学应用,比如生物制剂的递送,传感,成像,和催化。了解组装-拆卸过程的机制和响应特性背后的结构决定因素对于设计具有可编程响应性的下一代纳米组件至关重要。在这次审查中,我们关注两亲性大分子组装的结构决定因素及其在刺激下的大分子水平变化,例如亲水亲油平衡(HLB)的破坏,解聚,去交联,以及组件中分子堆积的变化,这最终导致了一系列用于实际目的的宏观现象。刺激响应性纳米组件在递送中的应用,根据其结构特征,对传感和成像进行了总结。我们希望这篇评论可以为读者提供纳米组装体设计和应用中的结构考虑因素的概述,并激励对刺激响应软物质的更多探索。
    Stimuli-responsive nano-assemblies from amphiphilic macromolecules could undergo controlled structural transformations and generate diverse macroscopic phenomenon under stimuli. Due to the controllable responsiveness, they have been applied for broad material and biomedical applications, such as biologics delivery, sensing, imaging, and catalysis. Understanding the mechanisms of the assembly-disassembly processes and structural determinants behind the responsive properties is fundamentally important for designing the next generation of nano-assemblies with programmable responsiveness. In this review, we focus on structural determinants of assemblies from amphiphilic macromolecules and their macromolecular level alterations under stimuli, such as the disruption of hydrophilic-lipophilic balance (HLB), depolymerization, decrosslinking, and changes of molecular packing in assemblies, which eventually lead to a series of macroscopic phenomenon for practical purposes. Applications of stimuli-responsive nano-assemblies in delivery, sensing and imaging were also summarized based on their structural features. We expect this review could provide readers an overview of the structural considerations in the design and applications of nanoassemblies and incentivize more explorations in stimuli-responsive soft matters.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    全球抗生素耐药性危机已引起人们的关注,即开发不易引起耐药性的治疗方法。如抗菌光动力疗法(aPDT)。然而,对能够在近红外(NIR)区域有效吸收的新型光敏剂的需求不断增加,使抗菌治疗在更深的地方。此外,需要制定先进的策略来避免因长期暴露而产生的耐药性。在这里,我们设计了一种共轭寡电解质,即TTQAd,具有供体-受体-供体(D-A-D)主链,能够在NIR光照射下产生活性氧(ROS),和侧链上的阳离子金刚烷铵基团,使用curcubit[7]uril(CB7)启用主客交互。由于TTQAd的两亲性,它可以在水溶液中自发形成纳米组装体。CB7治疗后,阳离子金刚烷铵基团的正电荷在很大程度上被CB7屏蔽,导致纳米组装体的进一步聚集和TTQAd的抗菌功效降低。随后与竞争对手的客人一起治疗可以释放TTQAd并恢复其抗菌作用。用于调节抗菌作用的可逆超分子开关为活性光敏剂的受控释放提供了潜力,从而显示出防止耐药细菌出现的希望。
    The global antibiotic resistance crisis has drawn attention to the development of treatment methods less prone to inducing drug resistance, such as antimicrobial photodynamic therapy (aPDT). However, there is an increasing demand for new photosensitizers capable of efficiently absorbing in the near-infrared (NIR) region, enabling antibacterial treatment in deeper sites. Additionally, advanced strategies need to be developed to avert drug resistance stemming from prolonged exposure. Herein, we have designed a conjugated oligoelectrolyte, namely TTQAd, with a donor-acceptor-donor (D-A-D) backbone, enabling the generation of reactive oxygen species (ROS) under NIR light irradiation, and cationic adamantaneammonium groups on the side chains, enabling the host-guest interaction with curcubit[7]uril (CB7). Due to the amphiphilic nature of TTQAd, it could spontaneously form nanoassemblies in aqueous solution. Upon CB7 treatment, the positive charge of the cationic adamantaneammonium group was largely shielded by CB7, leading to a further aggregation of the nanoassemblies and a reduced antibacterial efficacy of TTQAd. Subsequent treatment with competitor guests enables the release of TTQAd and restores its antibacterial effect. The reversible supramolecular switch for regulating the antibacterial effect offers the potential for the controlled release of active photosensitizers, thereby showing promise in preventing the emergence of drug-resistant bacteria.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    由于缺乏肿瘤特异性,大多数目前的抗癌疗法与主要副作用相关。已知使用工程化纳米载体的药物的适当载体化增加肿瘤中治疗分子的局部浓度,同时使其副作用最小化。间皮素(MSLN)是一种众所周知的肿瘤相关抗原,在许多恶性肿瘤中过度表达,特别是在恶性胸膜间皮瘤(MPM)中,目前在临床前和临床测定中评估了各种MSLN靶向抗癌疗法。在这项研究中,我们描述,第一次,用靶向MSLN的纳米抗体(Nb)对荧光有机纳米组装体(NA)进行功能化,以特异性靶向表达MSLN的MPM癌细胞。
    使用表达或不表达MSLN的来自不同癌症起源的细胞系。使用点击化学将针对MSLN的Nb与荧光NA偶联。一组胞吞抑制剂用于研究细胞的靶向NA内化。癌细胞在2D或3D和流动下生长以评估靶向NA的特异性。使用流式细胞术研究靶向NA的结合和内化,共聚焦显微镜和透射电子显微镜。
    我们显示靶向的NA与表达MSLN的肿瘤细胞特异性结合。此外,与MSLN+MPM细胞中的裸NA相比,这种功能化的NA似乎内化得更快,比例明显更大,从而证明了主动靶向策略的功能和兴趣。我们证明,靶向NA主要通过非网格蛋白依赖性/动力蛋白依赖性内吞途径内化,并针对溶酶体进行降解。基于表达MSLN的多细胞肿瘤球体的3D细胞培养模型揭示了NA在第一浅层中的渗透。
    总之,这些结果为基于MSLN激活的NA整合药物内化以促进肿瘤中主动治疗的特异性积累的新型抗癌策略开辟了道路.
    UNASSIGNED: Most current anti-cancer therapies are associated with major side effects due to a lack of tumor specificity. Appropriate vectorization of drugs using engineered nanovectors is known to increase local concentration of therapeutic molecules in tumors while minimizing their side effects. Mesothelin (MSLN) is a well-known tumor associated antigen overexpressed in many malignancies, in particular in malignant pleural mesothelioma (MPM), and various MSLN-targeting anticancer therapies are currently evaluated in preclinical and clinical assays. In this study, we described, for the first time, the functionalization of fluorescent organic nanoassemblies (NA) with a nanobody (Nb) targeting MSLN for the specific targeting of MSLN expressing MPM cancer cells.
    UNASSIGNED: Cell lines from different cancer origin expressing or not MSLN were used. An Nb directed against MSLN was coupled to fluorescent NA using click chemistry. A panel of endocytosis inhibitors was used to study targeted NA internalization by cells. Cancer cells were grown in 2D or 3D and under a flow to evaluate the specificity of the targeted NA. Binding and internalization of the targeted NA were studied using flow cytometry, confocal microscopy and transmission electron microscopy.
    UNASSIGNED: We show that the targeted NA specifically bind to MSLN-expressing tumor cells. Moreover, such functionalized NA appear to be internalized more rapidly and in significantly larger proportions compared to naked ones in MSLN+ MPM cells, thereby demonstrating both the functionality and interest of the active targeting strategy. We demonstrated that targeted NA are mainly internalized through a clathrin-independent/dynamin-dependent endocytosis pathway and are directed to lysosomes for degradation. A 3D cell culture model based on MSLN-expressing multicellular tumor spheroids reveals NA penetration in the first superficial layers.
    UNASSIGNED: Altogether, these results open the path to novel anticancer strategies based on MSLN-activated internalization of NA incorporating drugs to promote specific accumulation of active treatments in tumors.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号